此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

Swing-MESH™植入物(Bioscience™,B。Braun™,法国B. Braun™)在腹腔镜 - 内窥镜内镜疝修复中的安全性和功效 - 多中心,前瞻性观察性研究。 (SMS)

2026年9月17日 更新者:Swissmed Hospital

This multicenter, prospective observational study aims to assess the safety and efficacy of the Swing-Mesh™ implant (THT BioScience™, distributed by B. Braun™, France) for laparoscopic-endoscopic inguinal hernia repair using TAPP or TEP techniques. Swing-Mesh™ is a lightweight, macroporous, three-dimensional mesh designed to conform anatomically to the myopectineal orifice without requiring fixation. Eligible adult patients undergoing elective repair will receive the implant. The primary endpoint is hernia recurrence within 6 months. Secondary endpoints include postoperative pain, groin discomfort, and early and late complications. The study will provide clinical evidence regarding the non-inferiority of this spatial, fixation-free mesh compared to standard devices in minimally invasive hernia surgery.

研究概览

地位

完全的

条件

详细说明

Laparoscopic techniques such as TAPP and TEP are currently recommended as the standard approach for inguinal hernia repair due to faster recovery, reduced postoperative pain, and lower complication rates compared to open surgery.

To address the limitations of flat meshes in minimally invasive procedures, three-dimensional implants have been developed. These are better suited to the anatomical structure of the myopectineal orifice (MPO), reducing the risk of mesh migration without the need for fixation.

Swing-Mesh™ is a new lightweight, macroporous 3D implant introduced to the Polish market in 2025. Its structure is based on thermally modified polypropylene fibers, eliminating the need for rigid stabilizing rings. The implant is suitable for both right- and left-sided hernias.

The aim of this study is to assess the safety and clinical performance of Swing-Mesh™ in real-world settings. The primary endpoint is the hernia recurrence rate within 6 months. Secondary outcomes include postoperative pain, early and late complications, and patient-reported groin discomfort.

This is a prospective, multicenter, observational cohort study. Consecutive patients undergoing elective laparoscopic inguinal hernia repair will be enrolled after providing informed consent. The Swing-Mesh™ (15×11 cm or 16×12 cm) will be implanted without fixation. Selected surgical steps will be documented (photo/video), anonymized, and stored on a secure research platform.

Follow-up will be conducted at 7-10 days, 30 days, 3 months, and 6 months postoperatively. Data will be collected via structured telephone interviews or in-person visits, as needed.

研究类型

观察性的

注册 (实际的)

323

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习地点

      • Gdansk、波兰、80-280
        • Swissmed Hospital
    • Gdańsk
      • Gdansk、Gdańsk、波兰、80-215
        • Swissmed Hospital

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

18年 及以上 (成人、年长者)

接受健康志愿者

不

有资格学习的性别

全部

取样方法

非概率样本

研究人群

Patients scheduled for elective laparoscopic-endoscopic inguinal hernia repair using the Swing-Mesh™ implant. The study population includes adult patients of both sexes who meet the inclusion criteria and do not have any of the specified exclusion criteria. Participants will be recruited from surgical centers in Poland.

描述

Inclusion Criteria:

  • elective groin hernia repair
  • age > 18 years
  • male and female patients can participate
  • eligibility for laparoendoscopic repair
  • signed written informed consent

Exclusion Criteria:

  • age <18 years
  • emergency surgery (incarcerated hernia)
  • contaminated surgical field
  • recurrent hernia
  • extremely large scrotal hernias with the need of other abdominal compartment syndrome (ACS) preventive procedures (botulin injection, bowel resection, preoperative progressive pneumoperitoneum - PPP)
  • M3 or M3+L1-3 (EHS classification) groin hernia confirmed during surgery

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 观测模型:COHORT
  • 时间观点:PROSPECTIVE

队列和干预

团体/队列
干预/治疗
Swing-Mesh™ Cohort

Patients undergoing elective laparoscopic-endoscopic inguinal hernia repair (TAPP or TEP) using the Swing-Mesh™ implant without fixation. Follow-up is conducted at 7-10 days, 30 days, 3 months, and 6 months to assess recurrence, pain, complications, and groin discomfort.

A lightweight, macroporous, three-dimensional polypropylene mesh implant developed by THT BioScience™ and distributed by B. Braun™, used in laparoscopic-endoscopic inguinal hernia repair without fixation. The mesh is designed to conform to the anatomical shape of the myopectineal orifice and is available in two sizes (15×11 cm or 16×12 cm).

其他名称:
  • Tht Bioscience网格,3D疝网,摇摆人,B。Braun网格

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
Hernia recurrence rate within 6 months
大体时间:6 months post-surgery

Incidence of clinically or radiologically confirmed inguinal hernia recurrence during a 6-month follow-up period. Expected recurrence rate: 2-4%.

6 months post-surgery

次要结果测量

结果测量
措施说明
大体时间
Postoperative pain intensity (Visual Analog Scale 0-10)
大体时间:7-10 days, 30 days, 3 months, and 6 months post-surgery

Evaluation of postoperative pain using the Visual Analog Scale (VAS) at specified time points. Chronic pain defined as pain ≥4/10 persisting beyond 3 months.

7-10 days, 30 days, 3 months, and 6 months post-surgery
Early and late postoperative complications
大体时间:Up to 6 months post-surgery

Assessment of complications such as wound infection, hematoma, and seroma within 30 days (early) and up to 6 months (late).

Up to 6 months post-surgery
Groin discomfort and foreign body sensation
大体时间:7-10 days, 30 days, 3 months, and 6 months post-surgery

Patient-reported outcomes regarding groin discomfort and sensation of a foreign body during scheduled follow-up interviews.

7-10 days, 30 days, 3 months, and 6 months post-surgery

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

调查人员

  • 学习椅:Mateusz Zamkowski, MD, PhD、Swissmed Hospital
  • 研究主任:Maciej Śmietański, prof.、Swissmed Hospital

出版物和有用的链接

负责输入研究信息的人员自愿提供这些出版物。这些可能与研究有关。

一般刊物

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (实际的)

2025年4月7日

初级完成 (实际的)

2025年8月30日

研究完成 (实际的)

2026年8月30日

研究注册日期

首次提交

2025年4月1日

首先提交符合 QC 标准的

2025年4月1日

首次发布 (实际的)

2025年4月8日

研究记录更新

最后更新发布 (实际的)

2026年9月21日

上次提交的符合 QC 标准的更新

2026年9月17日

最后验证

2026年9月1日

更多信息

与本研究相关的术语

计划个人参与者数据 (IPD)

计划共享个人参与者数据 (IPD)?

是的

IPD 计划说明

De-identified individual participant data (e.g., recurrence outcomes, VAS scores) may be shared upon reasonable request, after publication of the study results.

IPD 共享时间框架

After completion of the study and publication of results

IPD 共享访问标准

Requests must be made by qualified researchers with a methodologically sound proposal, subject to approval by the study investigators.

IPD 共享支持信息类型

  • 研究方案
  • 树液
  • 国际碳纤维联合会
  • 企业社会责任

药物和器械信息、研究文件

研究美国 FDA 监管的药品

不

研究美国 FDA 监管的设备产品

不

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

订阅